Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

• Päätekijät: Peter E. Penson (Tekijä), Eric Bruckert (Tekijä), David Marais (Tekijä), Željko Reiner (Tekijä), Matteo Pirro (Tekijä), Amirhossein Sahebkar (Tekijä), Gani Bajraktari (Tekijä), Erkin Mirrakhimov (Tekijä), Manfredi Rizzo (Tekijä), Dimitri P. Mikhailidis (Tekijä), Alexandros Sachinidis (Tekijä), Dan Gaita (Tekijä), Gustavs Latkovskis (Tekijä), Mohsen Mazidi (Tekijä), Peter P. Toth (Tekijä), Daniel Pella (Tekijä), Fahad Alnouri (Tekijä), Arman Postadzhiyan (Tekijä), Hung‐I Yeh (Tekijä), G.B. John Mancini (Tekijä), Stephan vonHaehling (Tekijä), Maciej Banach (Tekijä), International Lipid Expert Panel (ILEP) (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Wiley, 2022-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Statin intolerance is a clinical syndrome whereby adverse effects (AEs) associated with statin therapy [most commonly statin‐associated muscle symptoms (SAMS)] result in the discontinuation of therapy and consequently increase the risk of adverse cardiovascular outcomes. However, complete s...